Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.

Álvarez-Marín R, López-Rojas R, Márquez JA, Gómez MJ, Molina J, Cisneros JM, Ortiz-Leyba C, Aznar J, Garnacho-Montero J, Pachón J.

PLoS One. 2016 Dec 19;11(12):e0168468. doi: 10.1371/journal.pone.0168468. eCollection 2016.

2.

Incidence, Clinical Outcome and Risk Factors of Intensive Care Unit Infections in the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

Iwuafor AA, Ogunsola FT, Oladele RO, Oduyebo OO, Desalu I, Egwuatu CC, Nnachi AU, Akujobi CN, Ita IO, Ogban GI.

PLoS One. 2016 Oct 24;11(10):e0165242. doi: 10.1371/journal.pone.0165242. eCollection 2016.

3.

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Ye JJ, Lin HS, Yeh CF, Wu YM, Huang PY, Yang CC, Huang CT, Lee MH.

BMC Infect Dis. 2016 Aug 5;16:374. doi: 10.1186/s12879-016-1717-6.

4.

Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.

Paramythiotou E, Routsi C.

World J Crit Care Med. 2016 May 4;5(2):111-20. doi: 10.5492/wjccm.v5.i2.111. eCollection 2016 May 4. Review.

5.

Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.

Tal-Jasper R, Katz DE, Amrami N, Ravid D, Avivi D, Zaidenstein R, Lazarovitch T, Dadon M, Kaye KS, Marchaim D.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3127-31. doi: 10.1128/AAC.02656-15. Print 2016 May.

6.

Bloodstream infections in the Intensive Care Unit.

Bassetti M, Righi E, Carnelutti A.

Virulence. 2016 Apr 2;7(3):267-79. doi: 10.1080/21505594.2015.1134072. Epub 2016 Jan 13. Review.

7.

Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.

Johnson TL, Waack U, Smith S, Mobley H, Sandkvist M.

J Bacteriol. 2015 Dec 14;198(4):711-9. doi: 10.1128/JB.00622-15.

8.

Nosocomial Isolates and Their Drug Resistant Pattern in ICU Patients at National Institute of Neurological and Allied Sciences, Nepal.

Bhandari P, Thapa G, Pokhrel BM, Bhatta DR, Devkota U.

Int J Microbiol. 2015;2015:572163. doi: 10.1155/2015/572163. Epub 2015 Oct 26.

9.

Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii.

Ellis D, Cohen B, Liu J, Larson E.

Antimicrob Resist Infect Control. 2015 Oct 9;4:40. doi: 10.1186/s13756-015-0083-2. eCollection 2015.

10.

Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.

Doan TN, Kong DC, Marshall C, Kirkpatrick CM, McBryde ES.

Virulence. 2016;7(2):141-52. doi: 10.1080/21505594.2015.1076615. Epub 2015 Aug 7.

11.
12.

Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.

Saravu K, Prasad M, Eshwara VK, Mukhopadhyay C.

Pathog Glob Health. 2015 Jul;109(5):228-35. doi: 10.1179/2047773215Y.0000000026. Epub 2015 Jul 17.

13.

Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.

Tiwari V, Roy R, Tiwari M.

Front Microbiol. 2015 Jun 18;6:618. doi: 10.3389/fmicb.2015.00618. eCollection 2015. Review.

14.

Characterising the Transmission Dynamics of Acinetobacter baumannii in Intensive Care Units Using Hidden Markov Models.

Doan TN, Kong DC, Marshall C, Kirkpatrick CM, McBryde ES.

PLoS One. 2015 Jul 1;10(7):e0132037. doi: 10.1371/journal.pone.0132037. eCollection 2015.

15.

Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.

Townsend J, Park AN, Gander R, Orr K, Arocha D, Zhang S, Greenberg DE.

Open Forum Infect Dis. 2015 Mar 12;2(1):ofv023. doi: 10.1093/ofid/ofv023. eCollection 2015 Jan. Erratum in: Open Forum Infect Dis. 2015 Jan;2(1):ofv041.

16.

Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure.

Cobos-Trigueros N, Solé M, Castro P, Torres JL, Hernández C, Rinaudo M, Fernández S, Soriano Á, Nicolás JM, Mensa J, Vila J, Martínez JA.

Crit Care. 2015 May 4;19:218. doi: 10.1186/s13054-015-0916-7.

17.

Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital.

Villalón P, Valdezate S, Cabezas T, Ortega M, Garrido N, Vindel A, Medina-Pascual MJ, Saez-Nieto JA.

BMC Microbiol. 2015 Feb 25;15:47. doi: 10.1186/s12866-015-0383-y.

18.

Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey.

Ece G, Erac B, Yurday Cetin H, Ece C, Baysak A.

Jundishapur J Microbiol. 2015 Feb 20;8(2):e15612. doi: 10.5812/jjm.15612. eCollection 2015 Feb.

19.

Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Lin MF, Lan CY.

World J Clin Cases. 2014 Dec 16;2(12):787-814. doi: 10.12998/wjcc.v2.i12.787. Review.

20.

A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.

Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA.

BMC Infect Dis. 2014 Nov 25;14:615. doi: 10.1186/s12879-014-0615-z.

Supplemental Content

Support Center